Table 6.
The changes in CGI score in the atypical group and the anxiety group
| Variables | Anxiety (n = 111) | Atypical (n = 63) | ||||||
|---|---|---|---|---|---|---|---|---|
| Enrolment n (%) |
3 months later n (%) |
Z1 | Enrolment n (%) |
3 months later n (%) |
6 months later n (%) |
Z2 | Z3 | |
| Disease severity | 2.583** | 0.674 | 2.435** | |||||
| No assessment | 0 | 0 | 0 | 0 | 0 | |||
| Normal | 0 | 5 (4.5) | 0 | 0 | 4 (6.3) | |||
| Borderline | 0 | 35 (31.5) | 0 | 0 | 23 (36.5) | |||
| Mild | 10 (9.0) | 55 (49.5) | 9 (14.3) | 12 (19.0) | 27 (42.9) | |||
| Moderate | 36 (32.4) | 16 (14.5) | 22 (34.9) | 25 (39.7) | 9 (14.3) | |||
| Obvious | 45 (40.5) | 0 | 24 (38.1) | 19 (30.2) | 0 | |||
| Severe | 12 (10.8) | 0 | 7 (11.1) | 6 (9.5) | 0 | |||
| Most severe | 8 (7.3) | 0 | 1 (1.6) | 1 (1.6) | 0 | |||
| Overall efficacy | 3.689*** | |||||||
| No assessment | 111 | 0 | 63 | 0 | 0 | 0.968 | 2.874** | |
| Obviously improved | 0 | 64 (57.7) | 0 | 0 | 41 (65.1) | |||
| Improved | 0 | 39 (35.1) | 0 | 0 | 16 (25.4) | |||
| Slightly improved | 0 | 8 (7.2) | 0 | 0 | 6 (9.5) | |||
| No change | 0 | 0 | 0 | 61 (96.8) | 0 | |||
| Slightly deteriorated | 0 | 0 | 0 | 2 (3.2) | 0 | |||
| Deteriorative | 0 | 0 | 0 | 0 | 0 | |||
| Obviously deteriorated | 0 | 0 | 0 | 0 | 0 | |||
**P < 0.01, ***P < 0.001
Z1 represents the comparison between enrolment and 3 months later in the anxiety group, Z2 represents the comparison between enrolment and 3 months later in the atypical group, Z3 represents the comparison between enrolment and 6 months later in the atypical group